tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market
CHM
Chimeric Therapeutics Ltd.
RESEARCH TOOLSreports
Want to see AU:CHM full AI Analyst Report?

Chimeric Therapeutics Ltd. (CHM) Income Statement

14 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q2 2026), Chimeric Therapeutics Ltd.'s total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q2, Chimeric Therapeutics Ltd.'s net income was AU$-11.22M. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 3.97MAU$ 7.46MAU$ 0.00AU$ 2.62MAU$ 2.65K
Gross Profit
AU$ 3.12MAU$ 7.45MAU$ 3.54MAU$ 1.67MAU$ -844.31K
Operating Expenses
AU$ 18.23MAU$ 19.77MAU$ 29.49MAU$ 13.62MAU$ 14.00M
Depreciation and Amortization
AU$ 1.03MAU$ 1.01MAU$ 965.35KAU$ 949.76KAU$ 846.96K
EBITDA
AU$ -9.08MAU$ -11.30MAU$ -28.59MAU$ -13.62MAU$ -14.26M
Operating Income
AU$ -15.11MAU$ -12.31MAU$ -29.49MAU$ -14.57MAU$ -14.85M
Other Income/Expenses
AU$ 4.79MAU$ -3.97MAU$ -842.60KAU$ -1.16MAU$ -267.02K
Pretax Income
AU$ -10.32MAU$ -16.28MAU$ -30.33MAU$ -15.73MAU$ -15.11M
Net Income
AU$ -10.43MAU$ -12.53MAU$ -25.92MAU$ -15.90MAU$ -15.11M
Per Share Metrics
Basic EPS
AU$ -0.77AU$ -1.80AU$ -5.98AU$ -4.42AU$ -4.64
Diluted EPS
AU$ -0.77AU$ -1.80AU$ -5.98AU$ -4.42AU$ -4.64
Weighted Average Shares Outstanding
 13.52M 6.96M 4.33M 3.60M 3.26M
Weighted Average Shares Outstanding (Diluted)
 13.52M 6.96M 4.33M 3.60M 3.26M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History